Results 261 to 270 of about 830,673 (331)

Prevalence of MSI‐H/dMMR Colorectal Cancer in Japan: Data From the Clinical Study Group of the University of Osaka‐Colorectal Registry

open access: yesAnnals of Gastroenterological Surgery, Volume 10, Issue 5, Page 1538-1545, September 2026.
Using a multicenter Japanese colorectal cancer cohort from 25 institutions, we analyzed 1464 patients across all disease stages and tumor locations to determine the prevalence and clinicopathological features of MSI‐H/dMMR colorectal cancer. MSI‐H/dMMR tumors accounted for 9.4% of cases overall, were present in 22% of right‐sided colon cancers, and ...
Yoshihiro Morimoto   +27 more
wiley   +1 more source

Predicting the Efficacy of Adjuvant Chemotherapy Using Immuno‐Nutritional and Inflammatory Markers in Elderly Patients With Stage III Colorectal Cancer

open access: yesAnnals of Gastroenterological Surgery, Volume 10, Issue 5, Page 1575-1585, September 2026.
This study aimed to determine whether immuno‐nutritional and inflammatory markers could serve as predictors of the outcomes of postoperative adjuvant chemotherapy for stage III colorectal cancer in elderly patients. Postoperative lymphocyte‐to‐monocyte ratio and postoperative C‐reactive protein‐to‐albumin ratio accurately predicted the efficacy of ...
Tomoya Tago   +6 more
wiley   +1 more source

Improved detection and quantification of peritoneal metastases using delayed contrast-enhanced dual-energy CT scans. [PDF]

open access: yesEur Radiol Exp
Bagnacci G   +11 more
europepmc   +1 more source

Long-Term Cytoreduction Outcomes With or Without Heated Intraperitoneal Chemotherapy For Colorectal Peritoneal Metastases. [PDF]

open access: yesJ Am Coll Surg
White MG   +9 more
europepmc   +1 more source

Intraperitoneal CF33-hNIS combined with PD-L1 blockade eradicates gastric cancer peritoneal metastases and prevents recurrence via durable T cell memory. [PDF]

open access: yesJ Immunother Cancer
Yang A   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy